Insider · CIK 0001376117
Lars Ekman
Files at PRTA (PROTHENA CORP PUBLIC LTD CO). First filing -, latest -.
In brief
Lars Ekman files SEC Form 4 as director at PRTA (PROTHENA CORP PUBLIC LTD CO). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Lars Ekman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 15, 2026 | PRTA PROTHENA CORP PUBLIC LTD CO | AGrant or award Stock Option (Right to Buy)derivative | +27,000 | $0.00 | $0 | 27,000 | May 15, 2026 |
| May 14, 2025 | PRTA PROTHENA CORP PUBLIC LTD CO | AGrant or award Stock Option (Right to Buy)derivative | +20,183 | $0.00 | $0 | 20,183 | May 16, 2025 |
Questions about Lars Ekman
Answered from the filings on this page, as of the latest one.
Is Lars Ekman buying or selling?
Lars Ekman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Lars Ekman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lars Ekman has 0.
Where does Lars Ekman file Form 4?
Lars Ekman has filed Form 4 at PRTA (PROTHENA CORP PUBLIC LTD CO). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.